| pubmed-article:21647357 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0018923 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0036270 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0023866 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0085973 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0007320 | lld:lifeskim |
| pubmed-article:21647357 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
| pubmed-article:21647357 | pubmed:dateCreated | 2011-6-7 | lld:pubmed |
| pubmed-article:21647357 | pubmed:abstractText | Angiosarcoma (AS) is a rare and aggressive vascular neoplasm with very poor prognosis. Patients with extensive cutaneous AS who are not surgical candidates have very limited options since there is no standard treatment. Treatment options include radiation, chemotherapy, and angiogenesis inhibitor with varying success rates. Here, we report a case an 88 year old patient with extensive scalp angiosarcoma having biopsy proven remission with bevacizumab and radiotherapy without undergoing surgery. | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21647357 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21647357 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:21647357 | pubmed:issn | 1369-1643 | lld:pubmed |
| pubmed-article:21647357 | pubmed:author | pubmed-author:SunDanyuD | lld:pubmed |
| pubmed-article:21647357 | pubmed:author | pubmed-author:PowellAngela... | lld:pubmed |
| pubmed-article:21647357 | pubmed:author | pubmed-author:RehmusEsther... | lld:pubmed |
| pubmed-article:21647357 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:21647357 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21647357 | pubmed:volume | 2011 | lld:pubmed |
| pubmed-article:21647357 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21647357 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21647357 | pubmed:pagination | 160369 | lld:pubmed |
| pubmed-article:21647357 | pubmed:dateRevised | 2011-7-28 | lld:pubmed |
| pubmed-article:21647357 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21647357 | pubmed:articleTitle | Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery: A Case Report and Review of the Literature. | lld:pubmed |
| pubmed-article:21647357 | pubmed:affiliation | Department of Medicine, Akron General Medical Center, 400 Wabash Avenue, Akron, OH 44307, USA. | lld:pubmed |
| pubmed-article:21647357 | pubmed:publicationType | Journal Article | lld:pubmed |
